BC Week In Review | May 7, 2007
Company News

BioServe Biotechnologies Ltd., SeraCare deal

BioServe acquired SRLS's Genomics Collaborative unit for $2 million in cash. The acquired business has a tissue and serum sample library linked to clinical and demographic data that it uses for biomarker discovery and validation....
BC Week In Review | Jun 14, 2004
Company News

Genomics Collaborative, SeraCare deal

SRLS will acquire Genomics Collaborative for 1.1 million shares and $800,000 in cash. Using SRLS's close of $12.25 on June 3 - the day before the deal was announced - the deal is valued at $14.3 million....
BC Week In Review | Apr 5, 2004
Company News

Celestar-Lexico Sciences Inc., Genomics Collaborative deal

The companies partnered to profile breast cancer genes. The deal combines Genomics Collaborative's annotated tissue samples and Celestar-Lexico's large-scale in-situ hybridization (LisH) technology, which creates gene expression image databases. Celestar-Lexico Sciences Inc. , Westwood, Mass.  ...
BC Week In Review | Mar 29, 2004
Company News

Genomics Collaborative, Whitehead Institute deal

Genomics Collaborative and the institute will use DNA samples from the company's Global Repository to study variations in the Y chromosome that may cause male infertility. The parties initially will study samples from 4,000 men...
BC Week In Review | Feb 2, 2004
Company News

Genomics Collaborative management update

Genomics Collaborative Inc. , Cambridge, Mass.   Business: Pharmacogenetics   Hired: Rick Episcopo as president, formerly EVP of commercial operations at Sequenom Inc.   Transition: Kevin Krenitsky to SVP of business development from SVP and medical...
BC Extra | Sep 22, 2003
Company News

Genomics Collaborative, NVS validation deal

Novartis' Novartis Institutes for BioMedical Research will use Genomics Collaborative's Global Repository database of human biological samples to validate drug targets from Novartis (NVS; SWX:NOVN). The two-year deal will encompass up to four therapeutic areas,...
BC Week In Review | Sep 22, 2003
Company News

Genomics Collaborative, Novartis deal

NVS's Novartis Institutes for BioMedical Research Inc. will use Genomics Collaborative's Global Repository database of human biological samples to validate NVS's drug targets. The two-year deal will encompass up to four therapeutic areas, including Type...
BioCentury | Sep 22, 2003
Strategy

Keeping the flame alive

Two companies, Genomics Collaborative and Graffinity, have done deals with big pharma and big biotech, respectively, which they said keep them on course as alternatives to the pure product development business model. Curating pays While...
BC Week In Review | Jan 20, 2003
Company News

Genomics Collaborative, Celera Diagnostics Inc. deal

Genomics Collaborative will provide Celera Diagnostics access to its DNA sample sets associated with rheumatoid arthritis (RA). Celera Diagnostics will analyze the samples to identify genetic markers for RA. The companies will share resulting data....
BC Extra | Jan 16, 2003
Company News

Genomics Collaborative, Celera Diagnostics deal

Genomics Collaborative (Cambridge, Mass.) will provide Celera Diagnostics (Alameda, Calif.) access to its DNA sample sets associated with rheumatoid arthritis (RA). Celera Diagnostics will analyze the samples to identify genetic markers for RA. The companies...
Items per page:
1 - 10 of 56
BC Week In Review | May 7, 2007
Company News

BioServe Biotechnologies Ltd., SeraCare deal

BioServe acquired SRLS's Genomics Collaborative unit for $2 million in cash. The acquired business has a tissue and serum sample library linked to clinical and demographic data that it uses for biomarker discovery and validation....
BC Week In Review | Jun 14, 2004
Company News

Genomics Collaborative, SeraCare deal

SRLS will acquire Genomics Collaborative for 1.1 million shares and $800,000 in cash. Using SRLS's close of $12.25 on June 3 - the day before the deal was announced - the deal is valued at $14.3 million....
BC Week In Review | Apr 5, 2004
Company News

Celestar-Lexico Sciences Inc., Genomics Collaborative deal

The companies partnered to profile breast cancer genes. The deal combines Genomics Collaborative's annotated tissue samples and Celestar-Lexico's large-scale in-situ hybridization (LisH) technology, which creates gene expression image databases. Celestar-Lexico Sciences Inc. , Westwood, Mass.  ...
BC Week In Review | Mar 29, 2004
Company News

Genomics Collaborative, Whitehead Institute deal

Genomics Collaborative and the institute will use DNA samples from the company's Global Repository to study variations in the Y chromosome that may cause male infertility. The parties initially will study samples from 4,000 men...
BC Week In Review | Feb 2, 2004
Company News

Genomics Collaborative management update

Genomics Collaborative Inc. , Cambridge, Mass.   Business: Pharmacogenetics   Hired: Rick Episcopo as president, formerly EVP of commercial operations at Sequenom Inc.   Transition: Kevin Krenitsky to SVP of business development from SVP and medical...
BC Extra | Sep 22, 2003
Company News

Genomics Collaborative, NVS validation deal

Novartis' Novartis Institutes for BioMedical Research will use Genomics Collaborative's Global Repository database of human biological samples to validate drug targets from Novartis (NVS; SWX:NOVN). The two-year deal will encompass up to four therapeutic areas,...
BC Week In Review | Sep 22, 2003
Company News

Genomics Collaborative, Novartis deal

NVS's Novartis Institutes for BioMedical Research Inc. will use Genomics Collaborative's Global Repository database of human biological samples to validate NVS's drug targets. The two-year deal will encompass up to four therapeutic areas, including Type...
BioCentury | Sep 22, 2003
Strategy

Keeping the flame alive

Two companies, Genomics Collaborative and Graffinity, have done deals with big pharma and big biotech, respectively, which they said keep them on course as alternatives to the pure product development business model. Curating pays While...
BC Week In Review | Jan 20, 2003
Company News

Genomics Collaborative, Celera Diagnostics Inc. deal

Genomics Collaborative will provide Celera Diagnostics access to its DNA sample sets associated with rheumatoid arthritis (RA). Celera Diagnostics will analyze the samples to identify genetic markers for RA. The companies will share resulting data....
BC Extra | Jan 16, 2003
Company News

Genomics Collaborative, Celera Diagnostics deal

Genomics Collaborative (Cambridge, Mass.) will provide Celera Diagnostics (Alameda, Calif.) access to its DNA sample sets associated with rheumatoid arthritis (RA). Celera Diagnostics will analyze the samples to identify genetic markers for RA. The companies...
Items per page:
1 - 10 of 56